BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36928526)

  • 1. [Retracted] Upregulation of the δ opioid receptor in liver cancer promotes liver cancer progression both
    Tang B; Li Y; Yuan S; Tomlinson S; He S
    Int J Oncol; 2023 May; 62(5):. PubMed ID: 36928526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retracted] SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling.
    Wang H; Liu H; Chen K; Xiao J; He K; Zhang J; Xiang G
    Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37083064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retracted] SIRT3 regulates cell proliferation and apoptosis related to energy metabolism in non‑small cell lung cancer cells through deacetylation of NMNAT2.
    Li H; Feng Z; Wu W; Li J; Zhang J; Xia T
    Int J Oncol; 2023 May; 62(5):. PubMed ID: 37026521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retracted] miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma.
    Liu K; Liu S; Zhang W; Ji B; Wang Y; Liu Y
    Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34726253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retracted] Synergistic effects of co‑expression plasmid‑based ADAM10‑specific siRNA and GRIM‑19 on hepatocellular carcinoma
    Liu S; Zhang W; Liu K; Wang Y; Ji B; Liu Y
    Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34841439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retracted] MicroRNA‑24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3.
    Zhang S; Zhang C; Liu W; Zheng W; Zhang Y; Wang S; Huang D; Liu X; Bai Z
    Int J Oncol; 2023 Jun; 62(6):. PubMed ID: 37083072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retracted] Embelin-induced brain glioma cell apoptosis and cell cycle arrest via the mitochondrial pathway.
    Wang A; Zhang B; Zhang J; Wu W; Wu W
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retracted] miR‑494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.
    Liu K; Liu S; Zhang W; Jia B; Tan L; Jin Z; Liu Y
    Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34850964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retracted] MicroRNA‑675 inhibits cell proliferation and invasion in melanoma by directly targeting metadherin.
    Liu K; Jin J; Rong K; Zhuo L; Li P
    Mol Med Rep; 2023 May; 27(5):. PubMed ID: 36999591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retracted] miR‑338‑3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2.
    Wen C; Liu X; Ma H; Zhang W; Li H
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retracted] MicroRNA‑15a‑5p‑targeting oncogene YAP1 inhibits cell viability and induces cell apoptosis in cervical cancer cells.
    Chen X; Cao R; Liu H; Zhang T; Yuan X; Xu S
    Int J Mol Med; 2024 Mar; 53(3):. PubMed ID: 38240105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retracted] miR‑133a inhibits cervical cancer growth by targeting EGFR.
    Song X; Shi B; Huang K; Zhang W
    Oncol Rep; 2021 Jul; 46(2):. PubMed ID: 34080664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retracted] miR‑17‑5p promotes the growth of osteosarcoma in a BRCC2‑dependent mechanism.
    Wang W; Zhang L; Zheng K; Zhang X
    Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38299268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retracted] Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma
    Liu J; Dong BF; Wang PS; Ren PY; Xue S; Zhang XN; Han Z; Chen G
    Oncol Rep; 2022 May; 47(5):. PubMed ID: 35234269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retracted] MicroRNA‑154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a.
    Zhou H; Zhang M; Yuan H; Zheng W; Meng C; Zhao D
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retracted] KIF22 promotes bladder cancer progression by activating the expression of CDCA3.
    Li K; Li S; Tang S; Zhang M; Ma Z; Wang Q; Chen F
    Int J Mol Med; 2023 Oct; 52(4):. PubMed ID: 37615186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retracted] Downregulation of long non‑coding RNA GACAT1 suppresses proliferation and induces apoptosis of NSCLC cells by sponging microRNA‑422a.
    Zhong Y; Lin H; Li Q; Liu C; Zhong L
    Int J Mol Med; 2024 Jan; 53(1):. PubMed ID: 37937638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retracted] Interaction of YAP1 and mTOR promotes bladder cancer progression.
    Xu M; Gu M; Zhou J; Da J; Wang Z
    Int J Oncol; 2024 May; 64(5):. PubMed ID: 38516763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retracted] MicroRNA‑132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4.
    Liu Y; Li Y; Liu J; Wu Y; Zhu Q
    Int J Oncol; 2023 Aug; 63(2):. PubMed ID: 37350407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin.
    Qu Y; Xia P; Zhang S; Pan S; Zhao J
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34726252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.